Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

The philanthropic arm of a major pharmaceutical company gave several Dallas-based nonprofits hundreds of thousands of dollars ...

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

Over the past three decades there have been amazing advances in treating and preventing HIV. It's now a manageable infection. A person with HIV who takes HIV medicine consistently, before their immune ...

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could ...

The consolidated evidence reveals that there is considerable cross-country price variation, particularly for second-line regimens where prices increase significantly with income level highlighting ...